|
US20070021493A1
(en)
|
1999-09-16 |
2007-01-25 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
US6545004B1
(en)
*
|
1999-10-27 |
2003-04-08 |
Cytokinetics, Inc. |
Methods and compositions utilizing quinazolinones
|
|
US7671200B2
(en)
|
1999-10-27 |
2010-03-02 |
Cytokinetics, Inc. |
Quinazolinone KSP inhibitors
|
|
US7230000B1
(en)
|
1999-10-27 |
2007-06-12 |
Cytokinetics, Incorporated |
Methods and compositions utilizing quinazolinones
|
|
US8852937B2
(en)
|
2000-03-30 |
2014-10-07 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
US7115653B2
(en)
|
2000-03-30 |
2006-10-03 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
MXPA03005152A
(es)
*
|
2000-12-11 |
2004-10-14 |
Tularik Inc |
Antogonista de cxcr3.
|
|
US6469002B1
(en)
*
|
2001-04-19 |
2002-10-22 |
Millennium Pharmaceuticals, Inc. |
Imidazolidine compounds
|
|
US6794379B2
(en)
|
2001-06-06 |
2004-09-21 |
Tularik Inc. |
CXCR3 antagonists
|
|
WO2003018549A2
(en)
*
|
2001-08-30 |
2003-03-06 |
Chemocentryx, Inc. |
Bicyclic compounds as inhibitors of chemokine binding to us28
|
|
JP2005507876A
(ja)
*
|
2001-09-05 |
2005-03-24 |
ミナーバ バイオテクノロジーズ コーポレイション |
癌を治療する組成物および方法
|
|
AU2002346471A1
(en)
*
|
2001-11-20 |
2003-06-10 |
Cytokinetics, Inc. |
Process for the racemization of chiral quinazolinones
|
|
WO2003070701A2
(en)
*
|
2002-02-15 |
2003-08-28 |
Cytokinetics, Inc. |
Syntheses of quinazolinones
|
|
ES2361403T3
(es)
|
2002-03-07 |
2011-06-16 |
X-Ceptor Therapeutics, Inc. |
Moduladores de quinazolinona de receptores nucleares.
|
|
US7381730B2
(en)
*
|
2002-03-15 |
2008-06-03 |
Bristol-Myers Squibb Company |
3-arylquinazoline derivatives as selective estrogen receptor beta modulators
|
|
JPWO2003082335A1
(ja)
*
|
2002-04-03 |
2005-07-28 |
住友製薬株式会社 |
新規血糖調節薬及びそのスクリーニング方法
|
|
US6900219B2
(en)
|
2002-04-04 |
2005-05-31 |
Cv Therapeutics, Inc. |
ABCA-1 elevating compounds
|
|
US20030225288A1
(en)
*
|
2002-04-12 |
2003-12-04 |
Millennium Pharmaceuticals, Inc. |
Imidazolidine compounds
|
|
AU2003234733B2
(en)
|
2002-04-17 |
2009-01-29 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
CA2485148A1
(en)
|
2002-05-09 |
2003-11-20 |
Cytokinetics, Inc. |
Pyrimidinone compounds, compositions and methods
|
|
US7214800B2
(en)
|
2002-05-09 |
2007-05-08 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
EP1513820A4
(en)
|
2002-05-23 |
2006-09-13 |
Cytokinetics Inc |
COMPOUNDS, COMPOSITIONS AND METHODS
|
|
EP2399903A1
(en)
*
|
2002-05-24 |
2011-12-28 |
Millennium Pharmaceuticals, Inc. |
Ccr9 inhibitors and methods of use thereof
|
|
WO2003106426A1
(en)
|
2002-06-14 |
2003-12-24 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
JP2005533119A
(ja)
|
2002-07-17 |
2005-11-04 |
サイトキネティクス・インコーポレーテッド |
化合物、組成物、及び方法
|
|
AU2003256805A1
(en)
*
|
2002-07-23 |
2004-02-09 |
Cytokinetics, Inc. |
Compounds compositions and methods
|
|
US20040048853A1
(en)
*
|
2002-08-21 |
2004-03-11 |
Gustave Bergnes |
Compounds, compositions, and methods
|
|
EP1554265A4
(en)
*
|
2002-09-13 |
2008-05-07 |
Cytokinetics Inc |
COMPOSITIONS, COMPOSITIONS AND M THODES
|
|
WO2004034972A2
(en)
|
2002-09-30 |
2004-04-29 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
MXPA05003607A
(es)
|
2002-10-04 |
2005-11-17 |
Prana Biotechnology Ltd |
Compuestos neurologicamente activos.
|
|
US7550590B2
(en)
*
|
2003-03-25 |
2009-06-23 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
|
WO2004092123A2
(en)
*
|
2003-04-10 |
2004-10-28 |
Microbia, Inc. |
Inhibitors of fungal invasion
|
|
JP2007507539A
(ja)
*
|
2003-10-06 |
2007-03-29 |
サイトキネティクス・インコーポレーテッド |
化合物、組成物及び方法
|
|
JP2007510652A
(ja)
*
|
2003-11-03 |
2007-04-26 |
サイトキネティクス・インコーポレーテッド |
ピリミジン−４−オン化合物、組成物、および方法
|
|
EP1680420A4
(en)
*
|
2003-11-07 |
2008-09-24 |
Cytokinetics Inc |
COMPOUNDS, COMPOSITIONS AND METHODS
|
|
EP1692112A4
(en)
|
2003-12-08 |
2008-09-24 |
Cytokinetics Inc |
COMPOUNDS, COMPOSITIONS, AND METHODS
|
|
US20090208486A1
(en)
*
|
2004-03-09 |
2009-08-20 |
Makoto Taketo |
Pharmaceutical composition comprising cxcr3 inhibitor
|
|
NZ551004A
(en)
|
2004-04-02 |
2010-07-30 |
Prana Biotechnology Ltd |
Neurologically-active compounds
|
|
US7271271B2
(en)
|
2004-06-28 |
2007-09-18 |
Amgen Sf, Llc |
Imidazolo-related compounds, compositions and methods for their use
|
|
US7939538B2
(en)
|
2004-06-28 |
2011-05-10 |
Amgen Inc. |
Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases
|
|
US7375102B2
(en)
*
|
2004-06-28 |
2008-05-20 |
Amgen Sf, Llc |
Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their use
|
|
EP1786265A4
(en)
*
|
2004-08-30 |
2009-08-19 |
Smithkline Beecham Corp |
NEW COMPOSITIONS AND PROCESSING METHODS
|
|
EP1790637B1
(en)
|
2004-09-13 |
2014-01-29 |
Ono Pharmaceutical Co., Ltd. |
Derivatives of N-4-piperidyl urea and medicaments containing them as active ingredient
|
|
EP1796675A4
(en)
*
|
2004-10-01 |
2009-03-04 |
Merck & Co Inc |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISEASES
|
|
US9512125B2
(en)
|
2004-11-19 |
2016-12-06 |
The Regents Of The University Of California |
Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents
|
|
US20110052612A1
(en)
|
2005-05-31 |
2011-03-03 |
Ono Pharmaceutical Co., Ltd. |
Spiropiperidine compound and medicinal use thereof
|
|
CA2612585A1
(en)
*
|
2005-06-27 |
2007-01-04 |
Amgen Inc. |
Anti-inflammatory aryl nitrile compounds
|
|
DE602006018176D1
(en)
*
|
2005-09-26 |
2010-12-23 |
Merck Sharp & Dohme |
N-(4-oxo-3,4-dihydrochinazolin-2-yl)butanamide als androgenrezeptormodulatoren
|
|
KR20090008217A
(ko)
|
2006-03-10 |
2009-01-21 |
오노 야꾸힝 고교 가부시키가이샤 |
질소 함유 복소환 유도체 및 이들을 유효 성분으로 하는 약제
|
|
WO2007114926A2
(en)
|
2006-04-04 |
2007-10-11 |
The Regents Of The University Of California |
Kinase antagonists
|
|
KR20080109096A
(ko)
|
2006-04-14 |
2008-12-16 |
프라나 바이오테크놀로지 리미티드 |
연령 관련 황반 변성（에이엠디）의 치료 방법
|
|
WO2008016006A1
(fr)
|
2006-07-31 |
2008-02-07 |
Ono Pharmaceutical Co., Ltd. |
Composé auquel un groupe cyclique est lié par une liaison spiro et son utilisation
|
|
EP3305915B1
(en)
*
|
2006-08-01 |
2022-01-26 |
Applied Biosystems, LLC |
Detection of analytes and nucleic acids
|
|
WO2008041118A2
(en)
*
|
2006-10-04 |
2008-04-10 |
Pfizer Products Inc. |
Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
|
|
US8273747B2
(en)
|
2006-11-02 |
2012-09-25 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
WO2008085828A2
(en)
|
2007-01-03 |
2008-07-17 |
The Johns Hopkins University |
Peptide modulators of angiogenesis and use thereof
|
|
GB2467670B
(en)
|
2007-10-04 |
2012-08-01 |
Intellikine Inc |
Chemical entities and therapeutic uses thereof
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
EP3613743B1
(en)
|
2008-01-04 |
2022-03-16 |
Intellikine, LLC |
Processes for the preparation of 1h-pyrazolo[3,4-d]pyrimidin-4-amine derivatives
|
|
US8637542B2
(en)
|
2008-03-14 |
2014-01-28 |
Intellikine, Inc. |
Kinase inhibitors and methods of use
|
|
US8993580B2
(en)
|
2008-03-14 |
2015-03-31 |
Intellikine Llc |
Benzothiazole kinase inhibitors and methods of use
|
|
US20110224223A1
(en)
|
2008-07-08 |
2011-09-15 |
The Regents Of The University Of California, A California Corporation |
MTOR Modulators and Uses Thereof
|
|
JP5788316B2
(ja)
|
2008-07-08 |
2015-09-30 |
インテリカイン， エルエルシー |
キナーゼインヒビターおよび使用方法
|
|
US8703778B2
(en)
|
2008-09-26 |
2014-04-22 |
Intellikine Llc |
Heterocyclic kinase inhibitors
|
|
WO2010045542A2
(en)
|
2008-10-16 |
2010-04-22 |
The Regents Of The University Of California |
Fused ring heteroaryl kinase inhibitors
|
|
US8476431B2
(en)
|
2008-11-03 |
2013-07-02 |
Itellikine LLC |
Benzoxazole kinase inhibitors and methods of use
|
|
WO2010129351A1
(en)
|
2009-04-28 |
2010-11-11 |
Schepens Eye Research Institute |
Method to identify and treat age-related macular degeneration
|
|
EP2427195B1
(en)
|
2009-05-07 |
2019-05-01 |
Intellikine, LLC |
Heterocyclic compounds and uses thereof
|
|
US8980899B2
(en)
|
2009-10-16 |
2015-03-17 |
The Regents Of The University Of California |
Methods of inhibiting Ire1
|
|
CA2799579A1
(en)
|
2010-05-21 |
2011-11-24 |
Intellikine, Inc. |
Chemical compounds, compositions and methods for kinase modulation
|
|
JP2013545749A
(ja)
|
2010-11-10 |
2013-12-26 |
インフィニティー ファーマシューティカルズ， インコーポレイテッド |
複素環化合物及びその使用
|
|
TWI674262B
(zh)
|
2011-01-10 |
2019-10-11 |
美商英菲尼提製藥股份有限公司 |
製備異喹啉酮之方法及異喹啉酮之固體形式
|
|
US9295673B2
(en)
|
2011-02-23 |
2016-03-29 |
Intellikine Llc |
Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof
|
|
WO2013012915A1
(en)
|
2011-07-19 |
2013-01-24 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
|
MX2014000648A
(es)
|
2011-07-19 |
2014-09-25 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos y sus usos.
|
|
KR20140075693A
(ko)
|
2011-08-29 |
2014-06-19 |
인피니티 파마슈티칼스, 인코포레이티드 |
헤테로사이클릭 화합물 및 그의 용도
|
|
MX370814B
(es)
|
2011-09-02 |
2020-01-08 |
Univ California |
Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas.
|
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
|
MX2015003874A
(es)
|
2012-09-26 |
2015-12-16 |
Univ California |
Modulacion de ire1.
|
|
EP2914296B2
(en)
|
2012-11-01 |
2021-09-29 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using pi3 kinase isoform modulators
|
|
US9481667B2
(en)
|
2013-03-15 |
2016-11-01 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
|
MX2021012208A
(es)
|
2013-10-04 |
2023-01-19 |
Infinity Pharmaceuticals Inc |
Compuestos heterocíclicos y usos de los mismos.
|
|
WO2015051241A1
(en)
|
2013-10-04 |
2015-04-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
NZ724368A
(en)
|
2014-03-19 |
2023-07-28 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
|
|
AR099789A1
(es)
*
|
2014-03-24 |
2016-08-17 |
Actelion Pharmaceuticals Ltd |
Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina
|
|
WO2015160975A2
(en)
|
2014-04-16 |
2015-10-22 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
|
WO2016054491A1
(en)
|
2014-10-03 |
2016-04-07 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
EP4585268A3
(en)
|
2015-09-14 |
2025-10-15 |
Twelve Therapeutics, Inc. |
Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
|
|
US10759806B2
(en)
|
2016-03-17 |
2020-09-01 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
|
|
WO2017214269A1
(en)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
RU2754507C2
(ru)
|
2016-06-24 |
2021-09-02 |
Инфинити Фармасьютикалз, Инк. |
Комбинированная терапия
|
|
JP7630801B2
(ja)
*
|
2020-07-13 |
2025-02-18 |
国立大学法人富山大学 |
Ｎｒ４ａ１拮抗薬を用いた鎮痛薬
|
|
US20230321063A1
(en)
*
|
2020-08-20 |
2023-10-12 |
Seattle Children's Hospital D/B/A Seattle Children's Research Institute |
Compositions and methods to reduce neuroinflammation
|